HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 12, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C ...

HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...

Non-ST-Elevation Myocardial Infarction or NSTEMI is as common as major heart attacks but ECG results are inconclusive, making early detection harder ...

Everus Construction Group, Inc. (ECG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...

HeartBeam (NASDAQ: BEAT) was featured among a select group of medical device companies in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and ...

Objective This pilot study sought to investigate the utility and acceptability of the KardiaMobile 6-lead ECG (KM6LECG) as a tool for remote monitoring in children with inherited cardiac conditions.

DiaCardia enables accurate prediabetes/diabetes screening using either 12-lead or single-lead electrocardiogram (ECG) data, demonstrating potential for scalable and accessible testing devices.

DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either 12-lead or single-lead electrocardiogram (ECG) data, has been developed. This ...

Magnetic Resonance Imaging (MRI) is widely utilized in veterinary medicine for its diagnostic accuracy and safety profile. However, thermal injuries secondary to MRI are a significant adverse event ...

HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...